These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice]. Matsumiya T, Freerksen E, Rosenfeld M. Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557 [No Abstract] [Full Text] [Related]
7. [Advances and principles in tuberculostatic therapy]. Bethge H. Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130 [No Abstract] [Full Text] [Related]
8. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs. Oka S, Motomiya M, Kato S, Sato H, Fujimoto M. Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094 [No Abstract] [Full Text] [Related]
12. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial. Steininger WJ. Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861 [No Abstract] [Full Text] [Related]
13. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man. Hokama S. Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098 [No Abstract] [Full Text] [Related]
14. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro]. Mkrtchian SV. Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355 [No Abstract] [Full Text] [Related]
15. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis. Kitamoto O, Oka S, Kawamori Y, Gomi J, Sugiyama K. Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959 [No Abstract] [Full Text] [Related]